Form 4: Surmodics SVP, Teri Woodwick Sides, Reports Stock Transaction

Teri Woodwick Sides, SVP at Surmodics, disposed of 1,312 shares of common stock to cover tax obligations.

Summary

• Teri Woodwick Sides, a Senior Vice President at Surmodics, filed a Form 4 indicating a transaction involving the company's stock.
• On November 30, 2024, Ms. Sides disposed of 1,312 shares of Surmodics common stock at a price of $39.45 per share.
• This transaction was categorized as a disposition to cover tax obligations.
• Following the transaction, Ms. Sides beneficially owns 35,649 shares of Surmodics common stock.
• The reported holdings include 480 shares acquired through the Employee Stock Purchase Plan for the phase ending 2/29/24 and 177 shares acquired for the phase ending 8/31/24.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to an insider stock transaction. It does not indicate any positive or negative sentiment about the company's performance or future prospects.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, as mandated by the SEC.
• Similar filings are made by executives at companies like Medtronic (MDT) and Boston Scientific (BSX) when they trade their company's stock.
• The transaction is typical for executives who may sell shares to cover tax obligations related to stock-based compensation.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale of shares by an executive.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Surmodics, stock transaction, Form 4, insider trading, Teri Woodwick Sides, SRDX, employee stock purchase plan